The European Union has approved a ban on animal testing for household cleaning products such as laundry detergents and kitchen cleaners, following a similar ban on cosmetics. The revised Detergents Regulation, effective immediately, will fully prohibit animal testing by mid-2029. This shift signals tighter compliance requirements for chemical suppliers and manufacturers targeting the EU market, with implications for global supply chains in industrial and consumer chemicals.
Regulatory timeline and scope
The European Parliament recently amended the Detergents Regulation to phase out animal testing in safety assessments for everyday cleaning products. A 42-month transition period is granted, with full prohibition taking effect from mid-2029. Both finished products and individual ingredients must be tested using scientifically validated non-animal methods only.
Industry and advocacy reactions
Eurogroup for Animals stated that the EU's new stance reflects growing recognition that science and ethics can coexist, noting that modern non-animal methods provide reliable safety data without harming animals. Dr. Tamara Zietek of Doctors Against Animal Experiments (DAAE) criticized animal testing as outdated and unreliable, emphasizing that true safety requires human-relevant technologies.
REACH reform and broader implications
DAAE and the European Coalition to End Animal Experiments (ECEAE) are pushing for amendments to the EU REACH regulation to close loopholes that still allow animal testing for many chemical ingredients. The European Commission is developing a roadmap to accelerate the transition to animal-free chemical testing, following a European Citizens' Initiative.
What buyers should watch
Suppliers exporting household chemicals or ingredients to the EU must prepare to submit non-animal safety data by mid-2029. This includes adopting alternative test methods such as organ-on-a-chip or in vitro assays. The shift may also affect REACH registration requirements, potentially increasing demand for validated non-animal testing services and technologies.
Global regulatory trends
Similar moves are underway worldwide: the US FDA has begun phasing out mandatory animal testing for drug development from 2025, the UK plans to replace key animal-based approval tests by 2026, and Switzerland is strengthening human-cell-based testing frameworks. These trends indicate a global reorientation of safety assessment markets toward human-relevant advanced technologies.
Source: Read the original report | Published: March 04, 2026